Industry / Germany

Germany Set To Abolish Prescription Charges

May 2006 | Market Trend Analysis

Printable version
Bookmark

Germany is preparing to drop the minimum EUR5 (US$6.40) prescription charge on certain drugs from July, in an effort to encourage patients to choose the most cost-effective

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Bayer Q210 Financial Results Reflects Increasing Reliance On Emerging Markets

Industry / Germany BMI Core View: Emerging markets will drive industry growth. The importance of emerging markets to large multinational drugmakers cannot be overstated and BMI's Pharmaceutical Expenditure Model reveals...

July 2010

The End Of Free Pricing?

Industry / Germany The German government has stepped up its focus on medicine prices. German Chancellor Angela Merkel's Cabinet has approved legislation that will require drug companies and health insurers to negotiate the...

July 2010

Stada Would Consider Takeover Offers

Industry / Germany German drug company Stada Arzneimittel could be a potential takeover target for multinational drugmaker Pfizer - after Chief Executive Hartmut Retzlaff's comments that the company would review potential...

June 2010

Parallel Export Worries Drugmakers

Industry / Germany The implementation of a market decree which will bring about 'short-term' price cuts of up to 27% on medicines in Greece is worrying drugmakers operating in the country. Drugmakers fear that not only...

June 2010

Tough Times Ahead For German Parallel Traders

Industry / Germany Focusing on new methods to control rising healthcare costs, German Health Minister Philipp Rösler is planning to abolish a law that makes it mandatory for 5% of the turnover of a pharmacy to be comprised...

May 2010